Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors

Leukemia

Volumn 28, Issue 4, 2014, Pages 749-760

  Sanchez, P V ^a   Glantz, S T ^a   Scotland, S ^a   Kasner, M T ^b   Carroll, M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

acute myeloid leukemia; liver X receptors; myeloid differentiation; retinoid X receptors; rexinoids

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; BEXAROTENE; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; RETINOIC ACID; RETINOID X RECEPTOR; ROSIGLITAZONE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR PU 1;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; BURST FORMING UNIT; CELL CYCLE ARREST; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSLATION; TRANSACTIVATION ASSAY;

CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; HYDROCARBONS, FLUORINATED; LEUKEMIA, MYELOID, ACUTE; NICOTINIC ACIDS; ORPHAN NUCLEAR RECEPTORS; PROTO-ONCOGENE PROTEINS; RETINOID X RECEPTORS; SULFONAMIDES; TETRAHYDRONAPHTHALENES; TRANS-ACTIVATORS; TRETINOIN;

EID: 84898484716     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.202     Document Type: Article

References (42)

1. Ablain J, de The H. Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood 2011; 117: 5795-5802.
2. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, angelo G et al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor {alpha} locus. Proc Natl Acad Sci USA 1991; 88: 1977-1981.
3. Juliusson G, Karlsson K, Lazarevic V, Wahlin A, Brune M, Antunovic P et al. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. Cancer 2011; 117: 4238-4246.
4. Tsai DE, Luger SM, Andreadis C, Vogl DT, Kemner A, Potuzak M et al. A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. Clin Cancer Res 2008; 14: 5619-5625.
5. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001; 81: 1269-1304. (Pubitemid 32606670)
6. Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S et al. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Blood 1996; 87: 1977-1984. (Pubitemid 26074102)
7. Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E et al. Rexinoidtriggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res 2005; 65: 8754-8765. (Pubitemid 41377364)
8. Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2006; 107: 3330-3338.
9. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 2004; 36: 624-630. (Pubitemid 38715991)
10. Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 2003; 101: 270-277. (Pubitemid 36025918)
11. Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2003; 101: 2074. (Pubitemid 36237622)
12. Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003; 4: 1029-1036. (Pubitemid 37265925)
13. Walsh JC, DeKoter RP, Lee HJ, Smith ED, Lancki DW, Gurish MF et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 2002; 17: 665-676. (Pubitemid 35351511)
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, CA) 2001; 25: 402-408. (Pubitemid 34164012)
15. Chen Q, Ross AC. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp Cell Res 2004; 297: 68-81. (Pubitemid 38759563)
16. Iijima K, Honma Y, Niitsu N. Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. Leuk Lymphoma 2004; 45: 1017-1024. (Pubitemid 38444679)
17. Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F, Roncaglia E et al. Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia. Leukemia 2006; 20: 1751-1758. (Pubitemid 44574986)
18. Howell SR, Shirley MA, Grese TA, Neel DA, Wells KE, Ulm EH. Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors. Drug Metab Dispos 2001; 29: 990-998. (Pubitemid 32605914)
19. Perez E, Bourguet W, Gronemeyer H, de Lera AR. Modulation of RXR function through ligand design. Biochim Biophys Acta 2011; 1821: 57-69.
20. Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K et al. Effects of novel RAR-and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 1999; 93: 2057-2066. (Pubitemid 29128509)
21. van de Merbel NC, van Veen JH, Wilkens G, Loewen G. Validated liquid chromatographic method for the determination of bexarotene in human plasma. Chromatogr 2002; 775: 189-195. (Pubitemid 34756415)
22. Kizaki M, Ueno H, Matsushita H, Takayama N, Muto A, Awaya N et al. Retinoid resistance in leukemic cells. Leuk Lymphoma 1997; 25: 427-434. (Pubitemid 27361887)
23. Park DJ, Chumakov AM, Vuong PT, Chih DY, Gombart AF, Miller Jr WH et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin invest 1999; 103: 1399-1408. (Pubitemid 29535496)
24. Lekstrom-Himes JA. The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem cells (Dayton, OH) 2001; 19: 125-133. (Pubitemid 32222237)
25. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene 2007; 26: 6816-6828. (Pubitemid 47585105)
26. Yoshida H, Ichikawa H, Tagata Y, Katsumoto T, Ohnishi K, Akao Y et al. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation. Mol Cell Biol 2007; 27: 5819-5834. (Pubitemid 47257836)
27. Kueh HY, Rothenberg EV. Regulatory gene network circuits underlying T cell development from multipotent progenitors. Wiley Interdiscip Rev Syst Biol Med 2011; 4: 79-102.
28. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 2011; 144: 296-309.
29. Konopleva M, Elstner E, McQueen TJ, Tsao T, Sudarikov A, Hu W et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther 2004; 3: 1249-1262. (Pubitemid 39440170)
30. Kohro T, Nakajima T, Wada Y, Sugiyama A, Ishii M, Tsutsumi S et al. Genomic structure and mapping of human orphan receptor LXR alpha: upregulation of LXRa mRNA during monocyte to macrophage differentiation. J Atheroscl Thromb 2000; 7: 145-151.
31. Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG et al. Selective expression of cholesterol metabolism genes in normal CD34\+CD38-cells with a heterogeneous expression pattern in AML cells. Exp Hemat 2006; 34: 622-630.
32. Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, Busby SA et al. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1- hydroxy-1-(trifluorometh yl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 2010; 77: 228-236.
33. Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011; 472: 491-494.
34. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002; 16: 1896-1905. (Pubitemid 35203432)
35. Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 2002; 16: 1940-1958. (Pubitemid 35203437)
36. Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S. Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood 2001; 97: 1314-1320. (Pubitemid 32183754)
37. Ricote M, Snyder CS, Leung HY, Chen J, Chien KR, Glass CK. Normal hematopoiesis after conditional targeting of RXRalpha in murine hematopoietic stem/progenitor cells. J Leuk Biol 2006; 80: 850-861. (Pubitemid 44835903)
38. Durual S, Rideau A, Ruault-Jungblut S, Cossali D, Beris P, Piguet V et al. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts. Leukemia 2007; 21: 1050-1059. (Pubitemid 46672082)
39. Szanto A, Nagy L. Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells. Mol Pharmacol 2005; 67: 1935-1943. (Pubitemid 41007775)
40. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998; 93: 229-240. (Pubitemid 28180856)
41. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-252. (Pubitemid 28180857)
42. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010; 328: 1689-1693.